neurological disorders", THE FASEB JOURNAL, vol.18, no.3, March 2004 (2004-03), pages 511-518, XP055033876, ISSN: 0892-6638, DOI: 10.1096/fj.03-0739com, LYDEN PATRICK D ET AL: "Combination therapy protects ischemic brain in rats: A glutamate antagonist plus a gamma-aminobutyric acid agonist", STROKE, LIPPINCOTT WILLIAMS & WILKINS, US, vol.25, no.1, 1994, pages 189-195, XP009160662, ISSN: 0039-2499, C. COSTA: "Coactivation of GABAA and GABAB Receptor Results in Neuroprotection During In Vitro Ischemia", STROKE, vol.35, no.2, February 2004 (2004-02), pages 596-600, XP055031403, ISSN: 0039-2499, DOI: 10.1161/01.STR.0000113691.32026.06, CUI ZHOU ET AL: "Neuroprotection of [gamma]-aminobutyric acid receptor agonists via enhancing neuronal nitric oxide synthase (Ser847) phosphorylation through increased neuronal nitric oxide synthase and PSD95 interaction and inhibited protein phosphatase activity in cerebral ischemia", JOURNAL OF NEUROSCIENCE RESEARCH, vol.86, no.13, October 2008 (2008-10), pages 2973-2983, XP055031404, ISSN: 0360-4012, DOI: 10.1002/jnr.21728, K. ENGELHARD ET AL: "Der neuroprotektive Einfluss des Glutamat-Antagonisten Acamprosat nach experimenteller zerebraler Ischämie", DER ANAESTHESIST, vol.49, no.9, 22 September 2000 (2000-09-22), pages 816-821, XP055031406, ISSN: 0003-2417, DOI: 10.1007/s001010070054, HAMA A T ET AL: "Synergistic interaction between intrathecal gamma-aminobutyrate (GABA) receptor agonists and an N-methyl-D-aspartate (NMDA) receptor antagonist in rats with neuropathic spinal cord injury pain", SOCIETY FOR NEUROSCIENCE ABSTRACT VIEWER AND ITINERARY PLANNER, vol.40, 2010, XP009161509, & 40TH ANNUAL MEETING OF THE SOCIETY-FOR-NEUROSCIENCE;

SAN DIEGO, CA, USA; NOVEMBER 13 -17, 2010

Enclosed is a translation of the patent claims in Norwegian. Please note that as per the Norwegian Patents Acts, section 66i the patent will receive protection in Norway only as far as there is agreement between the translation and the language of the application/patent granted at the EPO. In matters concerning the validity of the patent, language of the application/patent granted at the EPO will be used as the basis for the decision. The patent documents published by the EPO are available through Espacenet (http://worldwide.espacenet.com) or via the search engine on our website here: https://search.patentstyret.no/